Register entry
ALPHARMA PHARMACEUTICALS LLC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 42
- Countries
- 0
Exclusivity
Patents and exclusivities
42| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7682633 | EMBEDAmorphine sulfate; naltrexone hydrochloride | use | Jun 2027 |
| 7682634 | EMBEDAmorphine sulfate; naltrexone hydrochloride | product | Jun 2027 |
| 8158156 | EMBEDAmorphine sulfate; naltrexone hydrochloride | use | Jun 2027 |
| 8846104 | EMBEDAmorphine sulfate; naltrexone hydrochloride | product | Jun 2027 |
| 8877247 | EMBEDAmorphine sulfate; naltrexone hydrochloride | product | Jun 2027 |
| 7815934 | EMBEDAmorphine sulfate; naltrexone hydrochloride | product | Dec 2027 |
| 8623418 | EMBEDAmorphine sulfate; naltrexone hydrochloride | use | Nov 2029 |
Enquiry
Common questions
- Is ALPHARMA PHARMACEUTICALS LLC FDA approved?
- ALPHARMA PHARMACEUTICALS LLC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.